Gain-of-"endocytic' function in mutant p53 cancer cells
Journal
The international journal of biochemistry & cell biology
Journal Volume
131
Date Issued
2021-02
Author(s)
Abstract
Beyond its well-known canonical function as a tumor suppressor, p53 is also involved in numerous cellular processes through altered transcription under both normal and pathological conditions. The functional diversity of p53 outputs is complex and dependent on cell context. However, the underlying mechanisms responsible for this diversity remain largely unclear. The emerging evidence of p53 mutations involved in regulating endocytic trafficking and signaling, in tandem to promote malignancy (invasion, exosome biogenesis and immune evasion), sheds light on possible mechanisms behind the p53-driven complexity. The interrelated nature of endocytic trafficking and receptor signaling that form dynamic and adaptable feedback loops - either positive or negative - functions to modulate multiple cellular outputs. Biasing the tunable endocytic trafficking and receptor signaling network by mutant p53 expands the purview of p53, allowing its contribution to diverse and aggressive phenotypes. In this review, we explore recent studies in which the novel role of mutant p53 in altering endocytic trafficking to bias receptor signaling and drive transforming phenotypes is revealed. Understanding the complex crosstalk of mutant p53, endocytic trafficking and receptor signaling will allow the development of therapies to selectively target p53-altered endocytic processes.
Subjects
Cell invasion; Exosome; Immune evasion; Mutant p53; Receptor recycling; Receptor tyrosine kinase; Signaling
SDGs
Other Subjects
dicer; protein p53; receptor; beta1 integrin; DEAD box protein; DICER1 protein, human; EGFR protein, human; epidermal growth factor receptor; Itgb1 protein, human; protein p53; ribonuclease III; cancer cell; cell invasion; cell migration; cell vacuole; do
Type
journal article